- Home
- GCO vs NERV Comparison
GCO vs NERV Comparison
Compare GCO & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GCO | NERV |
|---|---|---|
| Founded | 1924 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 286.0M | 301.6M |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GCO | NERV |
|---|---|---|
| Price | $38.08 | $4.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $33.00 | $10.50 |
| AVG Volume (30 Days) | ★ 145.6K | 127.0K |
| Earning Date | 06-03-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 171.84 | N/A |
| EPS | ★ 1.25 | N/A |
| Revenue | ★ $2,606,898,000.00 | $41,175,600.00 |
| Revenue This Year | $0.78 | N/A |
| Revenue Next Year | $2.12 | N/A |
| P/E Ratio | $29.05 | ★ N/A |
| Revenue Growth | ★ 13.71 | N/A |
| 52 Week Low | $19.62 | $1.55 |
| 52 Week High | $38.95 | $12.46 |
Technical Indicators
Market Signals| Indicator | GCO | NERV |
|---|---|---|
| Relative Strength Index (RSI) | 66.79 | 37.37 |
| Support Level | $30.79 | $3.69 |
| Resistance Level | $38.95 | $5.61 |
| Average True Range (ATR) | 1.88 | 0.42 |
| MACD | 0.41 | -0.02 |
| Stochastic Oscillator | 93.49 | 33.05 |
Price Performance
Historical ComparisonAbout GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.